Skip to main content

Targeted Atomic Therapy is Hope for Many Cancers

The process of giving a beam-emitting iodine atom to the patient, commonly known as atomic therapy, has been giving hope to many cancer treatments in recent years. Explaining that targeted molecules are marked in nuclear medicine laboratories and injected intravenously to a patient, Nuclear Medicine Specialist Nalan Alan Selçuk sttated that “Thyroid cancer patients have a recovery rate over 90 percent with a single dose of iodine. This process also contributes to the treatment of neuroendocrine tumour at a rate of 82 percent”.

Pointing out that cancer is a health problem with an increasing incidence, Yeditepe University Hospital Department of Nuclear MedicineAssoc. Prof. Nalan Alan Selçuk shared important information about 'nuclear medicine treatment methods' and their success rates. Stating that atomic therapy has been used especially in the treatment of thyroid cancer since the early 1940s, Assoc. Prof. Dr. Nalan Alan Selçuk said, “For the last 20 years, we have started to use this treatment extensively in prostate cancer and tumors originating from neurons and nerve cells originating from the intestine and stomach, which we call neuroendocrine tumors, as well as liver tumors”. 

You can visit yeditepehealthcare.org for the rest of the news...